ACOXL |
Q9NUZ1
|
acyl-CoA oxidase like
|
Enzyme
|
5.2E-15 |
0.674 |
0.577 |
ATXN2 |
Q99700
|
ataxin 2
|
Nucleic acid binding
|
0.85 |
0.482 |
0.808 |
BACH2 |
Q9BYV9
|
BTB domain and CNC homolog 2
|
|
1.00 |
0.539 |
0.731 |
BCL2 |
P10415
|
BCL2 apoptosis regulator
|
Signaling
|
0.56 |
0.291 |
0.885 |
CARD8 |
Q9Y2G2
|
caspase recruitment domain family member 8
|
|
1.8E-06 |
0.590 |
0.731 |
CASP8 |
Q14790
|
caspase 8
|
Enzyme
|
3.7E-06 |
0.404 |
0.923 |
CD69 |
Q07108
|
CD69 molecule
|
|
3.0E-02 |
0.488 |
0.923 |
CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
CLEC16A |
Q2KHT3
|
C-type lectin domain containing 16A
|
|
0.28 |
0.612 |
0.654 |
CTSH |
P09668
|
cathepsin H
|
Enzyme
|
1.3E-08 |
0.626 |
0.654 |
ENTPD1 |
P49961
|
ectonucleoside triphosphate diphosphohydrolase 1
|
Enzyme
|
8.1E-03 |
0.499 |
0.769 |
ERBB3 |
P21860
|
erb-b2 receptor tyrosine kinase 3
|
Kinase
|
1.7E-15 |
0.448 |
0.808 |
ETS1 |
P14921
|
ETS proto-oncogene 1, transcription factor
|
Transcription factor
|
0.78 |
0.444 |
0.731 |
FOXP1 |
Q9H334
|
forkhead box P1
|
|
1.00 |
0.460 |
0.808 |
GCKR |
Q14397
|
glucokinase regulator
|
|
8.5E-19 |
0.604 |
0.615 |
HCP5 |
Q6MZN7
|
HLA complex P5
|
|
|
0.595 |
0.808 |
HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
HLA-DQA1 |
P01909
|
major histocompatibility complex, class II, DQ alpha 1
|
Immune response
|
2.4E-02 |
0.416 |
0.846 |
HLA-DRB9 |
|
major histocompatibility complex, class II, DR beta 9 (pseudogene)
|
|
|
0.682 |
0.654 |
ICAM1 |
P05362
|
intercellular adhesion molecule 1
|
|
3.5E-02 |
0.364 |
0.962 |
IKZF3 |
Q9UKT9
|
IKAROS family zinc finger 3
|
Transcription factor
|
0.98 |
0.608 |
0.692 |
IL2RA |
P01589
|
interleukin 2 receptor subunit alpha
|
Receptor
|
5.5E-02 |
0.389 |
0.885 |
IL7 |
P13232
|
interleukin 7
|
|
0.93 |
0.464 |
0.808 |
IRF1-AS1 |
Q8N8D9
|
IRF1 antisense RNA 1
|
|
4.2E-03 |
0.670 |
0.385 |